CRAC intermediate 2

• Description :

  CRAC intermediate 2 (the starting compound in example 23) is an intermediate. CRAC intermediate 2 can be used in the research of CRAC inhibitors[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  CRAC Channel; Drug Intermediate

• Type :

  Reference compound

• Related Pathways :

  Membrane Transporter/Ion Channel; Others

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/CRAC-intermediate-2.html

• Purity :

  99.45

• Solubility :

  DMSO : ≥ 52 mg/mL

• Smiles :

  NC1=CC=C(N2N=C(C(F)(F)F)C=C2C(F)(F)F)C=C1

• Molecular Formula :

  C11H7F6N3

• Molecular Weight :

  295.18

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Cao, et al. Compounds that modulate intracellular calcium. WO2013059666A1. WIPO (PCT) . 2012-10-19.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [123066-64-8]